Dental provider vaccination recommendations, a parent accepted strategy for disease prevention

Lisa A Waiwaiole, Michelle L Henninger, Daniel J Pihlstrom, Michael C Leo, David M Mosen, Allison L Naleway
{"title":"Dental provider vaccination recommendations, a parent accepted strategy for disease prevention","authors":"Lisa A Waiwaiole, Michelle L Henninger, Daniel J Pihlstrom, Michael C Leo, David M Mosen, Allison L Naleway","doi":"10.15406/jcpcr.2019.10.00404","DOIUrl":null,"url":null,"abstract":"Recommended vaccines for adolescents between the ages of 11-17 years in the United States (U.S.) are tetanus-diphtheriaacellular pertussis (Tdap), meningococcal conjugate (MCV4), human papillomavirus (HPV), and seasonal influenza (flu). While U.S. vaccine coverage rates for Tdap and MCV4 approach Healthy People target goals of 80%, coverage rates are 43% for HPV1 and 49% for flu.2 The American Academy of Paediatrics cites the need for improvement in vaccination rates.3 A model suggests that increasing HPV vaccine coverage to 80% for 13 birth cohorts of U.S. girls 12 and under could avoid 53,300 lifetime cervical cancer cases.4 Given that most flu-associated pediatric deaths are in children who were not vaccinated, estimates show that vaccination could reduce risk of death by 50% for children in high-risk categories and two-thirds for children with no high-risk conditions.5 With pertussis disease rates increasing,6 increased vaccination coverage could prevent death and disease. Renewed strategies are needed to address low vaccination rates.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Prevention & Current Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jcpcr.2019.10.00404","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Recommended vaccines for adolescents between the ages of 11-17 years in the United States (U.S.) are tetanus-diphtheriaacellular pertussis (Tdap), meningococcal conjugate (MCV4), human papillomavirus (HPV), and seasonal influenza (flu). While U.S. vaccine coverage rates for Tdap and MCV4 approach Healthy People target goals of 80%, coverage rates are 43% for HPV1 and 49% for flu.2 The American Academy of Paediatrics cites the need for improvement in vaccination rates.3 A model suggests that increasing HPV vaccine coverage to 80% for 13 birth cohorts of U.S. girls 12 and under could avoid 53,300 lifetime cervical cancer cases.4 Given that most flu-associated pediatric deaths are in children who were not vaccinated, estimates show that vaccination could reduce risk of death by 50% for children in high-risk categories and two-thirds for children with no high-risk conditions.5 With pertussis disease rates increasing,6 increased vaccination coverage could prevent death and disease. Renewed strategies are needed to address low vaccination rates.
牙科医生建议接种疫苗,是家长接受的疾病预防策略
在美国,11-17岁的青少年推荐接种的疫苗有破伤风-白喉-无细胞百日咳(Tdap)、脑膜炎球菌结合疫苗(MCV4)、人乳头瘤病毒(HPV)和季节性流感(流感)。虽然美国百白破和MCV4疫苗的覆盖率接近80%的健康人目标,但hpv疫苗的覆盖率为43%,流感疫苗的覆盖率为49%美国儿科学会指出需要提高疫苗接种率一个模型表明,将13组12岁及以下美国女孩的HPV疫苗覆盖率提高到80%,可以避免53,300例终生宫颈癌病例鉴于大多数与流感相关的儿童死亡都发生在未接种疫苗的儿童中,估计表明,接种疫苗可将高危类别儿童的死亡风险降低50%,将无高危情况儿童的死亡风险降低三分之二随着百日咳发病率的增加,增加疫苗接种率可以预防死亡和疾病。需要更新战略以解决疫苗接种率低的问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书